³í¹®) In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair °¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø ¼øȯ±â³»°ú ¹ÚÈÆÁØ ±³¼ö, Æ÷½ºÅØ ÀåÁø¾Æ ±³¼ö, È«Äá½Ã¸³´ë ¹Ý±â¿ø ±³¼ö